Novartis (NVS)
(Delayed Data from NYSE)
$97.44 USD
-1.62 (-1.64%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $97.41 -0.03 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum C VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 21% (198 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.45 | 2.10 | 9.99 |
Current Quarter Estimate | 1.81 | 37.64 | 60.00 |
Year Ago Quarter Estimate | 1.83 | 11.39 | 52.54 |
Next Quarter Estimate | 1.83 | 34.85 | 61.00 |
Next Year Estimate | 8.06 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 4.64 | 3.90 | 17.08 |
Next Year | 11.63 | 16.10 | 8.00 |
Last 5 Years | 6.40 | 3.00 | 8.10 |
Next 5 Years | 8.60 | 11.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 14.36 | 15.53 |
Price/Book (MRQ) | 5.09 | 5.30 |
Price/Cash Flow (MRFY) | 8.91 | 10.16 |
Dividend Yield | 2.45% | 2.85% |
Net Profit Margin (TTM) | 31.33% | 45.26% |
Return on Equity (TTM) | 32.15% | 36.43% |
Debt to Equity (MRQ) | 0.43 | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.